USPTO 2015–2025 USPTO PatentsView US Corporation

Covidien Lp

USPTO PatentsView assignee record - 6,485 granted patents across 183 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

6,485

Total patents granted

183

CPC technology areas

16.2

Avg claims per patent

-5%

5-year filing velocity

The verdict

Covidien holds 6,485 US patents across 183 technology areas, rank #57 of 50,000 tracked assignees.

#57
of 50,000 US assignees by volume: Top 0.1%
by Innovation Score (70.9/100): 16.2
avg claims per patent: -5%
filing velocity, last 5 yrs

Portfolio overview

Covidien Lp has been granted 6,485 US utility patents between 2015 and 2025, placing Covidien Lp at rank #57 across all assignees tracked by PlainPatent. This portfolio spans 183 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Covidien Lp is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Covidien sits between Honeywell International Inc. (7,183 patents, rank #53) and Capital ONE Services, Llc (5,990 patents, rank #61) - the closest US assignees by grant volume. The composite Innovation Score of 70.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3,165 grants, compared with 3,320 in the 2015–2019 window, a -5% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Covidien Lp's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Covidien Lp against peers pursuing similar technology classes.

Honeywell Interna…

7,183
Siemens Aktienges…

7,003
Applied Materials

6,997
LG CHEM

6,727
Covidien ◀

6,485
The Regents of th…

6,428
Saudi Arabian OIL

6,393
3M Innovative Pro…

5,993
Capital ONE Servi…

5,990

What this shows Covidien holds 6,485 patents at rank #57, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Covidien

By rank, the assignees closest to #57 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Covidien's primary technology class.

Covidien's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

71 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Covidien Lp patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	808	12.5%
2016	679	10.5%
2017	659	10.2%
2018	572	8.8%
2019	602	9.3%
2020	684	10.5%
2021	569	8.8%
2022	597	9.2%
2023	598	9.2%
2024	432	6.7%
2025	285	4.4%

Which technologies does Covidien Lp patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 5,709

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 726

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 528

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 295

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 226

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 198

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 174

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 152

B25J - MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES 93

G06F - ELECTRIC DIGITAL DATA PROCESSING 83

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 79

H01R - ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS 64

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 59

F16H - GEARING 57

H01Q - ANTENNAS, i.e. RADIO AERIALS 54

Top 15 of 183 technology areas

Patent Moat Analysis

Portfolio Volume Strong

Tech Breadth Diversified

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#57

Across all tracked assignees

Innovation Score

70.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Covidien Lp hold?

Covidien Lp holds 6,485 US granted patents filed between 2015 and 2025, spanning 183 technology areas.

What is Covidien Lp's Innovation Score?

Covidien Lp has an Innovation Score of 70.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Covidien Lp focus on?

Covidien Lp's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 5,709 patents. The company has filed patents in 183 CPC subclasses total.

Is Covidien Lp's patent filing rate increasing or decreasing?

Covidien Lp's recent filing velocity is -5% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Covidien Lp's patents?

Covidien Lp's patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Covidien Lp patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Covidien's 6,485 grants land it in the top 0.1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Covidien ranks #57 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.